These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10822219)

  • 41. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
    Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3088-90. PubMed ID: 7559902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Large-scale analysis of mutations in RET exon 16 in sporadic medullary thyroid carcinomas in Japan.
    Takano T; Miyauchi A; Yoshida H; Hasegawa Y; Kuma K; Amino N
    Jpn J Cancer Res; 2001 Jun; 92(6):645-8. PubMed ID: 11429053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.
    Eng C; Mulligan LM; Healey CS; Houghton C; Frilling A; Raue F; Thomas GA; Ponder BA
    Cancer Res; 1996 May; 56(9):2167-70. PubMed ID: 8616867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis.
    Peacock ML; Borst MJ; Sweet JD; Decker RA
    Hum Mutat; 1996; 7(2):100-4. PubMed ID: 8829625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.
    Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Kuma S; Kuma K; Futami H; Yamaguchi K
    World J Surg; 2000 Nov; 24(11):1367-72. PubMed ID: 11038208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
    Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
    Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A new inherited RET proto-oncogene mutation associated with familial medullary thyroid carcinoma and polymorphisms in adjacent regions].
    Kalinin VN; Amosenko FA; Puskas C; Frilling A; Broelsch CE
    Genetika; 1998 Aug; 34(8):1157-9. PubMed ID: 9777362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.
    Ruiz A; Antiñolo G; Fernández RM; Eng C; Marcos I; Borrego S
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):399-402. PubMed ID: 11589684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.
    Fitze G; Schierz M; Bredow J; Saeger HD; Roesner D; Schackert HK
    Ann Surg; 2002 Nov; 236(5):570-5. PubMed ID: 12409662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
    Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma].
    Wohllk N; Becker P; Youlton R; Cote GJ; Gagel RF
    Rev Med Chil; 2001 Jul; 129(7):713-8. PubMed ID: 11552438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.
    Wiench M; Wygoda Z; Gubala E; Wloch J; Lisowska K; Krassowski J; Scieglinska D; Fiszer-Kierzkowska A; Lange D; Kula D; Zeman M; Roskosz J; Kukulska A; Krawczyk Z; Jarzab B
    J Clin Oncol; 2001 Mar; 19(5):1374-80. PubMed ID: 11230481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type.
    Yoshimoto K; Tanaka C; Hamaguchi S; Kimura T; Iwahana H; Miyauchi A; Itakura M
    Endocr J; 1995 Apr; 42(2):265-70. PubMed ID: 7627271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
    Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
    Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary.
    Klein I; Esik O; Homolya V; Szeri F; Váradi A
    J Endocrinol; 2001 Sep; 170(3):661-6. PubMed ID: 11524247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.
    Fattoruso O; Quadro L; Libroia A; Verga U; Lupoli G; Cascone E; Colantuoni V
    Hum Mutat; 1998; Suppl 1():S167-71. PubMed ID: 9452077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.